In this study, we induced pro-inflammatory conditions in FLS using recombinant interleukin 17 (IL-17) and tumor necrosis factor alpha (TNF-α) treatment, as these cytokines are critical in RA pathogenesis rather than OA [13, 14]. Here, IL17A is linked to rheumatoid arthritis.